Table 3. Leu-Enkephalin and Insulin B chain dual substrate assays.
Mutant NEP | leu-ENK | Insulin B Chain | Ratio leu-ENK insulin B chain |
pmole/min/ng | pmole/min/ng | ||
NEP | 1.16±0.06 (0.61) | 0.20±0.04 (0.23) | 5.8 |
NEPF563V | 0.23±0.03 (0.74) | 0.04±0.01 (0.67) | 5.8 |
NEPF563L | 0.97±0.06 (0.62) | 0.19±0.03 (0.20) | 5.1 |
NEPF563M | 0.69±0.11 (0.57) | 0.11±0.02 (0.52) | 6.3 |
NEPF563I | 0.62±0.03 (0.58) | 0.02±0.01 (0.15) | 31.0 |
NEPS546E | 0.76±0.14 (0.68) | 0.25±0.01 (0.43) | 3.0 |
The numbers in parenthesis indicate activity relative to the uninhibited values.
Reactions were carried out at 37°C at in 20 mM MES buffer, pH 6.5 containing 15 µM insulin B chain and 64 µM leu-ENK. Activity was measured and statistical analysis carried out as in Table 2 .